PHOSPHOLIPASE-C ACTIVITY IN PLATELETS FROM BERNARD-SOULIER SYNDROME PATIENTS

Citation
A. Mcnicol et al., PHOSPHOLIPASE-C ACTIVITY IN PLATELETS FROM BERNARD-SOULIER SYNDROME PATIENTS, Arteriosclerosis and thrombosis, 13(11), 1993, pp. 1567-1571
Citations number
44
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
10498834
Volume
13
Issue
11
Year of publication
1993
Pages
1567 - 1571
Database
ISI
SICI code
1049-8834(1993)13:11<1567:PAIPFB>2.0.ZU;2-Y
Abstract
The levels of glycoprotein (GP) Ib and GPV and phospholipase C activit y were measured in platelets from three Bernard-Soulier syndrome patie nts. The patients' platelets had 46%, 46%, and 24% of control levels o f GPIbalpha and 43%, trace, and 13% of control levels of GPV as determ ined by immunoblot analysis. Stimulation by thrombin, trypsin, the thr omboxane analogue U46619, and the combination of U46619 and trypsin ca used the formation of [P-32]phosphatidic acid, an index of phospholipa se C activity, in [P-32] orthophosphate-prelabeled platelets. With all agonists, however, the formation of [P-32] phosphatidic acid was mark edly reduced in Bernard-Soulier syndrome platelets compared with contr ol platelets. These data indicated a postreceptor defect in phospholip ase C activation in Bernard-Soulier syndrome platelets and confirmed e arlier observations of potential proteolytic and nonproteolytic mechan isms of platelet activation.